• LinkedIn

The Business of Biofabrication

  • News
  • Perspectives
  • Learn

R.D. Solorzano

  • Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs
    April 8, 2025

    Xylyx Bio Secures $1.125 Million to Advance Innovations in Xenogeneic Cross-Circulation Transplant Organs

    R.D. Solorzano
  • Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies
    April 3, 2025

    Organovo Sells FXR Drug Program to Eli Lilly in Strategic Deal to Advance IBD Therapies

    R.D. Solorzano
  • LyGenesis Receives Green Light to Advance Organ Regeneration Trial
    April 3, 2025

    LyGenesis Receives Green Light to Advance Organ Regeneration Trial

    R.D. Solorzano
  • How Cellino and Matricelf are Advancing Neural Tissue Engineering
    March 18, 2025

    How Cellino and Matricelf are Advancing Neural Tissue Engineering

    R.D. Solorzano
  • CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program
    March 18, 2025

    CollPlant Biotechnologies Update – Reports Q3 2024 Results, Advances Regenerative Breast Implant Program

    R.D. Solorzano
  • Vericel – Poised for Growth with Expanding Indications and Strong Margins
    March 18, 2025

    Vericel – Poised for Growth with Expanding Indications and Strong Margins

    R.D. Solorzano
  • Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application
    March 7, 2025

    Sernova Biotherapeutics Secures FDA Clearance for Thyroid Cell Pouch IND Application

    R.D. Solorzano
  • Nurami Medical Secures $30 Million to Accelerate Meningeal Tissue Repair Innovation
    March 7, 2025

    Nurami Medical Secures $30 Million to Accelerate Meningeal Tissue Repair Innovation

    R.D. Solorzano
  • Trestle Bio Announces Research Collaboration with Humacyte
    March 6, 2025

    Trestle Bio Announces Research Collaboration with Humacyte

    R.D. Solorzano
  • Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch
    February 26, 2025

    Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch

    R.D. Solorzano
Previous Page
1 … 4 5 6 7 8 … 12
Next Page

Archives

To make sense of, stay update on, and learn about
the business of biofabrication

Subscribe

2024 All Rights Reserved

  • Subscribe Subscribed
    • The Business of Biofabrication
    • Already have a WordPress.com account? Log in now.
    • The Business of Biofabrication
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar